Results:

Pharma Reputations: Managing Perceptions

14 08 2012

Geneva-based Covalence, a company that markets the information system, EthicalQuote, has observed that pharma is not keeping pace with other industries in terms of the overall balance of global good and bad news coverage in four broad ethical areas: labour standards, waste management, product social utility and human rights policy. “The pharma industry is losing [...]


Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

30 01 2012

Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade. Uniting efforts with NTD-endemic countries, partners pledged to [...]


Pledge of $150m to fight neglected diseases

14 10 2010

Six pharmaceutical companies and several governments have pledged more than $150m in medicines and funding over five years to tackle some of the most neglected diseases. The debilitating illnesses – including leprosy, lymphatic filariasis and sleeping sickness – affect 1bn of the world’s poorest people, place a burden on health services, stunt children’s education and [...]


World Business and Development Award winners: Fighting poverty can benefit business

21 09 2010

Ten companies were recognized today at this year’s World Business and Development Awards (WBDA) for their efforts in improving the lives of some of the world’s most disadvantaged communities. The winning companies are engaged in diverse initiatives such as providing low-income housing in Mexico; assisting farmers in Sierra Leone integrate into sorghum value chains, and [...]


Appel à clarifier les prélèvements d’organes sur des prisonniers en Chine

16 08 2010

Amnesty International Suisse veut un code de conduite pour les entreprises actives dans la transplantation d’organes en Chine, un pays qui utilise des condamnés à mort. Novartis répond favorablement. Roche se tait. Ils seront plus de 4000 experts à participer dès dimanche à Vancouver au 23e congrès interna­tional de la Société de transplantation: médecins, chirurgiens, [...]


Companies call for ‘credible’ climate action

23 09 2009

A group of 500 global businesses, including dozens of Australian corporations, have called for “credible” action on climate change. The publication of the so-called Copenhagen Communique comes two months before the UN climate change conference in Copenhagen in December, amid fears the meeting will fail to put in place an agreement to effectively cut the [...]


Novartis rejects call for vaccine donations

12 06 2009

Novartis, the Swiss pharmaceuticals group, defied the World Health Organisation and some of its corporate peers by ruling out a donation to the poor of vaccines to counter the latest flu pandemic, and saying developing nations or donor nations should cover the costs. Daniel Vasella, Novartis chief executive, told the Financial Times that he would [...]


Parachutes dorés : le Medef et l’Afep veulent une France exemplaire

6 10 2008

Le Medef a horreur des décisions de circonstance mais, cette fois, la pression politique est telle qu’il n’a plus le choix. Moins de deux ans après avoir émis des recommandations sur la rémunération des dirigeants, suite aux affaires Forgeard (EADS) et Zacharias (Vinci), l’organisation présidée par Laurence Parisot dévoile ce matin un « code de [...]


Global malaria action plan launched to eradicate malaria by 2015

27 09 2008

“Malaria defeated the international community many years ago. We cannot allow this to happen again. A single global action plan for malaria control, that enjoys partnership-wide support, is a strong factor for success,†said Margaret Chan, Director-General of the World Health Organization (WHO) at the launch of the new Global Malaria Action Plan (GMAP) in [...]


Pharmas Challenged by Product Risk and Philanthropy Fatigue – Covalence Pharmaceutical Industry Report 2008

9 09 2008

Increased attention on product human risk and smaller media coverage of drug donations have challenged Pharmaceuticals’ ethical reputation last year, states a report published today by Geneva-based research firm Covalence – Covalence Pharmaceutical Industry Report 2008. The pharmaceutical industry dropped from the first to the third rank of Covalence all-time EthicalQuote ranking across 10 industries. [...]